Skip to content

Drug interactions

Daunorubicin + Lonafarnib

Severity: Moderate

Daunorubicin and Lonafarnib: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lonafarnib is a weak P-glycoprotein inhibitor and may modestly increase exposure to daunorubicin, a P-gp substrate. Because daunorubicin has a narrow therapeutic index, even small increases may matter.

What this interaction means in plain words

Daunorubicin and Lonafarnib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Daunorubicin belongs to Oncology; Lonafarnib belongs to Miscellaneous.

Evidence level: Low

Why it happens

Lonafarnib inhibition of P-glycoprotein efflux may raise daunorubicin concentrations.

What to do

Monitor blood counts, mucositis and cardiac function, and reduce the daunorubicin dose if adverse effects occur.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Daunorubicin and Lonafarnib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Daunorubicin with Lonafarnib?

MediHelp rates the interaction as moderate. Daunorubicin and Lonafarnib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lonafarnib is a weak P-glycoprotein inhibitor and may modestly increase exposure to daunorubicin, a P-gp substrate. Because daunorubicin has a narrow therapeutic index, even small increases may matter.

How serious is the interaction between Daunorubicin and Lonafarnib?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood counts, mucositis and cardiac function, and reduce the daunorubicin dose if adverse effects occur.

What other medicines interact with Daunorubicin?

MediHelp also lists interactions of Daunorubicin with, for example, Adenovirus types 4 and 7 live, Belatacept, Cyclosporin. The full list is on the Daunorubicin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in